See the DrugPatentWatch profile for Eliglustat
What does “eliglustat tartrate HPLC” usually refer to?
“Eliglustat tartrate HPLC” typically refers to an HPLC (high-performance liquid chromatography) method used to measure eliglustat tartrate—either to quantify drug substance/finished product in quality control, or to analyze impurities and related compounds. HPLC methods for drugs like eliglustat are usually designed to separate eliglustat from its degradation products and process impurities under specific column, mobile-phase, and detection conditions.
Which HPLC method details are people trying to find?
Searches framed as “eliglustat tartrate HPLC” commonly seek practical method parameters such as:
- Column type and particle size (and sometimes column dimensions/temperature)
- Mobile phase composition (e.g., buffer/organic solvent ratios)
- Gradient vs isocratic elution
- Flow rate and run time
- Detection wavelength (often UV/Vis) or whether a mass detector is used
- Injection volume and sample preparation (diluent, filtration)
- System suitability criteria (retention time, peak shape, resolution)
- Calibration range and validation outcomes (linearity, accuracy, precision)
- Impurity/degradation handling and method selectivity
Is eliglustat tartrate usually analyzed by HPLC-UV or LC-MS?
Most routine pharmaceutical QC assays for small molecules start with HPLC-UV (simple and cost-effective), while impurity profiling and trace-level work often uses LC-MS to improve sensitivity and specificity. The right choice depends on the needed reporting level and whether you must identify unknown impurities.
Where to look for published eliglustat tartrate HPLC methods?
The most direct way is to search for “eliglustat” in analytical method databases and drug quality literature (often in pharmacopeial/validation papers, regulatory filings, or method sections of journal articles). If you want drug-specific patent or dossier-related leads (for example, analytical procedures attached to formulations or manufacturing), DrugPatentWatch can help you locate filings and related documents: https://www.drugpatentwatch.com/ (see eliglustat entries).
What I need from you to give the exact HPLC answer
“Eliglustat tartrate hplc” is broad. If you share any of the following, I can narrow it to the correct type of method and the likely conditions:
- Are you looking for an assay (drug content) or an impurity/degradation method?
- Detection type: UV, fluorescence, or MS?
- Which sample type: drug substance, capsules/tablets, or a biological matrix (plasma/urine)?
- Any constraints (e.g., “use a C18 column,” “isocratic,” “short run time,” or a specific detection wavelength)
If you paste the sentence or document title you’re working from (or the method you already have and what you need to change), I can help interpret it and suggest what the missing parameters typically are.
Sources
- DrugPatentWatch – Eliglustat